TFF Pharmaceuticals, Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in TFF Pharmaceuticals, Inc..
Log in to see more information.
TFFP Fundamental Data by TradingView

News

TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment
TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment

Seeking Alpha - Healthcare TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment...\n more…

TFF Pharmaceuticals announces new partnership with Emory University, BARDA
TFF Pharmaceuticals announces new partnership with Emory University, BARDA

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

TFF Pharmaceuticals announces preclinical data from influenza vaccine candidates
TFF Pharmaceuticals announces preclinical data from influenza vaccine candidates

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Roth Capital Comments on TFF Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:TFFP)
Roth Capital Comments on TFF Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:TFFP)

Ticker Report TFF Pharmaceuticals, Inc. (NASDAQ:TFFP - Free Report) - Roth Capital upped their Q3 2024 earnings estimates for TFF Pharmaceuticals in a research note issued to investors on Wednesday, August 14th...\n more…

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Expected to Post FY2027 Earnings of $1.81 Per Share
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Expected to Post FY2027 Earnings of $1.81 Per Share

Ticker Report TFF Pharmaceuticals, Inc. (NASDAQ:TFFP - Free Report) - Stock analysts at Roth Capital decreased their FY2027 EPS estimates for TFF Pharmaceuticals in a research report issued to clients and...\n more…

TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nTFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second...\n more…